Literature DB >> 12889086

Olfactory bulb in multiple system atrophy.

Tibor Kovács1, Mátyás I Papp, Nigel J Cairns, M Nadeem Khan, Peter L Lantos.   

Abstract

Olfactory dysfunction is a characteristic clinical sign in Parkinson's disease (PD); it is also present in multiple system atrophy (MSA). The pathological basis of hyposmia or anosmia in PD is well known: the olfactory bulb (OB) contains numerous Lewy bodies and severe neuronal loss is present in the anterior olfactory nucleus (AON). We established that glial cytoplasmic inclusions (GCIs) are present in all the OBs from MSA cases. Their presence in the OB is diagnostic for MSA. Additionally, neuronal loss is present in the AON in MSA. These pathological changes might be responsible for the olfactory dysfunction seen in MSA. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12889086     DOI: 10.1002/mds.10466

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

1.  Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.

Authors:  Kiren Ubhi; Edward Rockenstein; Michael Mante; Chandra Inglis; Anthony Adame; Christina Patrick; Kristen Whitney; Eliezer Masliah
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study.

Authors:  A Mueller; N D Abolmaali; A R Hakimi; T Gloeckler; B Herting; H Reichmann; T Hummel
Journal:  J Neural Transm (Vienna)       Date:  2005-02-15       Impact factor: 3.575

Review 3.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

4.  Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.

Authors:  Koichi Wakabayashi; Yasuo Miki; Kunikazu Tanji; Fumiaki Mori
Journal:  Cerebellum       Date:  2022-04-26       Impact factor: 3.847

5.  Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.

Authors:  Thomas G Beach; Charles L White; Christa L Hladik; Marwan N Sabbagh; Donald J Connor; Holly A Shill; Lucia I Sue; Jeanne Sasse; Jyothi Bachalakuri; Jonette Henry-Watson; Haru Akiyama; Charles H Adler
Journal:  Acta Neuropathol       Date:  2008-11-04       Impact factor: 17.088

Review 6.  [Olfactory dysfunction in Parkinson's disease: its role as a new cardinal sign in early and differential diagnosis].

Authors:  B Herting; S Bietenbeck; K Scholz; A Hähner; T Hummel; H Reichmann
Journal:  Nervenarzt       Date:  2008-02       Impact factor: 1.214

7.  Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?

Authors:  Hiroshige Fujishiro; Tae-Beom Ahn; Roberta Frigerio; Anthony DelleDonne; Keith A Josephs; Joseph E Parisi; J Eric Ahlskog; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2008-06-14       Impact factor: 17.088

8.  Biopsable neural tissues: toward new biomarkers for Parkinson's disease?

Authors:  Thibaud Lebouvier; Maddalena Tasselli; Sébastien Paillusson; Hélène Pouclet; Michel Neunlist; Pascal Derkinderen
Journal:  Front Psychiatry       Date:  2010-09-03       Impact factor: 4.157

9.  The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.

Authors:  Masahiko Suzuki; Masaya Hashimoto; Masayuki Yoshioka; Maiko Murakami; Keiichi Kawasaki; Mitsuyoshi Urashima
Journal:  BMC Neurol       Date:  2011-12-22       Impact factor: 2.474

10.  Intact olfaction in a mouse model of multiple system atrophy.

Authors:  Florian Krismer; Gregor K Wenning; Yuntao Li; Werner Poewe; Nadia Stefanova
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.